GUTSVSPACB• 7 Days (Normalized)
GUTS vs PACB (Fractyl Health Inc. vs Pacific Biosciences of California Inc.)
Showing Closing Date Range from Sep 29 to Oct 6, 2026.
Normalized cumulative comparison anchored at 0.00% baseline to illustrate pure alpha, return divergence, and market momentum.
GUTS Performance $4.56
+1021.5%
Fractyl Health Inc.
Normalized Baseline0.00%
PACB Performance $2.87
+56.83%
Pacific Biosciences of California Inc.
Normalized Baseline0.00%
Alpha Spread Margin GUTS LEADS
+964.67 pts
GUTS outperforming by 964.67 percentage points
GUTSPACB
Spread Trajectory7 Days (Normalized)
Cumulative Performance Trajectory
Interactive divergence comparison normalized at 0.00% on start date.
GUTS PACB
Comparative Historical Ledger
Daily closing prices, normalized percentages, and relative spread divergence.
Historical Quotes & Breakdown(5 dates)
| Date | GUTS Price | GUTS Gain (%) | PACB Price | PACB Gain (%) | Spread |
|---|---|---|---|---|---|
| Oct 05, 2026 | $4.56 | +1021.50% | $2.87 | +56.83% | +964.67% |
| Oct 02, 2026 | $0.41 | +0.00% | $2.54 | +38.80% | -38.80% |
| Oct 01, 2026 | $- | $2.51 | +37.16% | - | |
| Sep 30, 2026 | $- | $2.37 | +29.51% | - | |
| Sep 29, 2026 | $- | $1.83 | +0.00% | - |